Oct 28, 2019
Visiongain Report Claims There is Huge Potential Within the $266bn Biologicals Market
Oct 25, 2019
AbbVie Announces Commencement of Exchange Offers and Consent Solicitations for Allergan Notes
Oct 25, 2019
Allergan Declares Fourth Quarter 2019 Cash Dividend of $0.74 Per Ordinary Share
Oct 23, 2019
Allergan Presents Data From Eleven Abstracts At The 2019 American Society for Dermatologic Surgery (ASDS) in Chicago
Oct 17, 2019
Allergan to Report Third Quarter 2019 Financial Results
Oct 17, 2019
Visiongain Report Looks at Opportunities Within the $32bn Ophthalmic Drugs Market
Oct 14, 2019
Allergan Shareholders Approve Proposed Acquisition by AbbVie
Oct 11, 2019
Allergan and Molecular Partners Present Late-Breaking Data from Phase 3 Studies of Investigational Abicipar pegol in Neovascular Wet Age-Related Macular Degeneration
Oct 10, 2019
On World Sight Day, Allergan Launches National Campaign to Raise Awareness of the Toll Glaucoma Takes on Everyday Living
Oct 09, 2019
Sosei Heptares to Receive US$3 Million Payment from Genentech on Nomination of a New GPCR Disease Target
Oct 08, 2019
The global eye infections therapeutics market at a CAGR of almost 3% during the forecast period
Oct 07, 2019
The Aesthetic Society Develops 'The Patient App' Through Support From Allergan®
Oct 07, 2019
Visiongain Report Looks at Opportunities Within the $257bn Rare Disease Drugs Market
Oct 03, 2019
Allergan to Showcase Late-Stage Data in Age-Related Macular Degeneration and Glaucoma at American Academy of Ophthalmology Annual Meeting
Sep 27, 2019
AbbVie and Allergan Receive Second Request from Federal Trade Commission on Pending Transaction
Sep 27, 2019
Allergan and AbbVie Receive Second Request from Federal Trade Commission on Pending Transaction
Sep 20, 2019
AbbVie Inc. - Despatch of Option Holder Proposal Letters
Sep 17, 2019
Allergan Announces Commencement of Mailing of Proxy Statement
Sep 12, 2019
Accuray Appoints Healthcare Veteran James M. Hindman to Board of Directors
Sep 12, 2019
Sosei Heptares Investor R&D Event Highlights Innovative Research and Development Approaches and Strong Pipeline Momentum